Activity of interferon-alpha in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma.
Armitage
J O
JO
University of Nebraska Medical Center, Department of Internal Medicine, Omaha 68198-3332, USA. joarmita@unmc.edu
Coiffier
B
B
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D017809:Fatal Outcome; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D012867:Skin / Q000473:pathology
D016898:Interferon-alpha